Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome
Diabetes-associated chronic kidney disease is a pandemic issue. Despite the global<br />increase in the number of individuals with this chronic condition together with increasing<br />morbidity and mortality, there are currently only limited therapeutic options to slow disease<br />...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-09-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/8/9/341 |